Unisphere Establishment’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$176M Buy
2,802,700
+626,000
+29% +$50.1M 1.48% 18
2025
Q4
$208M Buy
2,176,700
+69,500
+3% +$6.81M 1.55% 18
2025
Q3
$206M Buy
2,107,200
+140,800
+7% +$14.6M 1.61% 17
2025
Q2
$211M Sell
1,966,400
-200,000
-9% -$20.2M 1.7% 15
2025
Q1
$219M Sell
2,166,400
-225,000
-9% -$22.7M 1.91% 14
2024
Q4
$214M Buy
2,391,400
+225,000
+10% +$19.8M 1.86% 15
2024
Q3
$182M Sell
2,166,400
-270,600
-11% -$21.3M 1.72% 18
2024
Q2
$188M Buy
2,437,000
+111,500
+5% +$8.16M 1.89% 17
2024
Q1
$159M Hold
2,325,500
1.61% 19
2023
Q4
$134M Buy
+2,325,500
New +$124M 1.39% 24

Other funds holding BSX

Unisphere Establishment's BSX Position: Q1 2026 in Review

Unisphere Establishment increased its Boston Scientific (BSX) stake by 29% in Q1 2026, buying an estimated $50.1M and bringing the position to 2,802,700 shares worth $176M. The position accounts for 1.48% of the portfolio, ranked #18.

Unisphere Establishment first reported a position in BSX in Q4 2023 and has held it in 10 quarters since. The position peaked at $219M in Q1 2025. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

  • Unisphere Establishment held 2,802,700 shares of Boston Scientific worth $176M as of Q1 2026.
  • Unisphere Establishment bought 626,000 Boston Scientific shares in Q1 2026, an estimated $50.1M.
  • Boston Scientific made up 1.48% of Unisphere Establishment's portfolio in Q1 2026, its #18 holding.
  • Unisphere Establishment first reported a position in Boston Scientific in Q4 2023 and has held it in 10 quarters since.
  • Unisphere Establishment's Boston Scientific position peaked at $219M in Q1 2025.
  • 1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Unisphere Establishment's 13F filing for Q1 2026, filed 14 May 2026.